SBLATTERO, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 11.953
EU - Europa 4.563
AS - Asia 1.272
Continente sconosciuto - Info sul continente non disponibili 22
AF - Africa 16
SA - Sud America 12
OC - Oceania 3
Totale 17.841
Nazione #
US - Stati Uniti d'America 11.929
PL - Polonia 980
SE - Svezia 928
UA - Ucraina 806
IT - Italia 693
CN - Cina 527
HK - Hong Kong 352
FI - Finlandia 302
TR - Turchia 288
BG - Bulgaria 165
DE - Germania 157
IE - Irlanda 157
GB - Regno Unito 138
FR - Francia 87
BE - Belgio 42
CH - Svizzera 25
CA - Canada 24
VN - Vietnam 21
EU - Europa 20
SG - Singapore 20
IN - India 16
HU - Ungheria 13
RU - Federazione Russa 13
NL - Olanda 12
SN - Senegal 12
BR - Brasile 10
KR - Corea 10
ES - Italia 8
JP - Giappone 7
RO - Romania 7
GR - Grecia 6
IR - Iran 6
ID - Indonesia 5
MY - Malesia 5
BD - Bangladesh 4
CZ - Repubblica Ceca 4
HR - Croazia 4
AT - Austria 3
NO - Norvegia 3
SI - Slovenia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
IL - Israele 2
IQ - Iraq 2
LV - Lettonia 2
PK - Pakistan 2
TW - Taiwan 2
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
Totale 17.841
Città #
Woodbridge 1.571
Fairfield 1.454
Ann Arbor 1.374
Houston 1.354
Warsaw 977
Chandler 940
Ashburn 853
Jacksonville 739
Wilmington 697
Seattle 632
Cambridge 489
Hong Kong 351
Princeton 310
Izmir 275
Trieste 254
Beijing 166
Sofia 164
Dublin 157
Boardman 103
Dearborn 85
San Diego 69
Milan 63
Bremen 57
Helsinki 48
Düsseldorf 43
Falls Church 43
Jinan 42
Brussels 40
Des Moines 36
Nanjing 28
Norwalk 26
Buffalo 25
Sacile 24
Washington 24
Chicago 23
Hefei 23
Verona 21
Bern 20
Dong Ket 18
Kunming 17
Fremont 16
Denver 15
Guangzhou 15
Mestre 15
Redwood City 15
Shenyang 15
Phoenix 14
Toronto 13
Dakar 12
Redmond 12
Budapest 10
Seoul 10
Columbus 9
San Francisco 9
Shanghai 9
Auburn Hills 8
Edinburgh 8
Kocaeli 8
Port Coquitlam 8
São Paulo 8
Torre Del Greco 8
Fuzhou 7
Hebei 7
London 7
Pune 7
Tulsa 7
Cascina 6
Detroit 6
Grafing 6
Leawood 6
Nanchang 6
Philadelphia 6
Tappahannock 6
Zhengzhou 6
Andover 5
Boston 5
Changsha 5
Hangzhou 5
Taizhou 5
Tianjin 5
Wuhan 5
Amsterdam 4
Brno 4
Chengdu 4
Chongqing 4
Doncaster 4
Dongguan 4
Frankfurt Am Main 4
Hamburg 4
Indiana 4
Paris 4
Piemonte 4
Pieris 4
San Mateo 4
Tokyo 4
Clearwater 3
Depok 3
Frankfurt am Main 3
Groningen 3
Hanoi 3
Totale 14.061
Nome #
SINEUPs are modular antisense long non-coding RNAs that increase synthesis of target proteins in cells 330
Targeted delivery of neutralizing anti-C5 antibody to renal endothelium prevents complement- dependent tissue damage 305
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia 300
Rational design of antirheumatic prodrugs specific for sites of inflammation 293
A non-complement-fixing antibody to  2 glycoprotein I as a novel therapy for antiphospholipid syndrome 226
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 215
Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063 210
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 190
The Use of Biopsy and "no-Biopsy" Approach for Diagnosing Paediatric Coeliac Disease in the Central European Region 181
An Albumin-Derived Peptide Scaffold Capable of Binding and Catalysis 180
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 178
The gut as site of production of autoimmune antibodies. 178
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 176
Autoantibodies as predictors of disease. 175
SINEUPs: A new class of natural and synthetic antisense long non-coding RNAs that activate translation 175
Using archaeal histones for precise DNA fragmentation , 20: 267-271 (2007) 174
Anti transglutaminase antibodies cause ataxia in mice. 173
Role of anti-osteopontin antibodies in multiple sclerosis and experimental autoimmune encephalomyelitis 172
Anti-transglutaminase antibodies and age. 169
null 166
Phage display technology for human monoclonal antibodies 165
null 163
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 161
Primer sets for cloning the human repertoire of T cell Receptor variable regions 157
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 154
Diagnostic Delays in Children with Coeliac Disease in the Central European Region 154
A reliable screening procedure for coeliac disease in clinical practice. 153
Recombinant antibody selections by combining phage and yeast display 153
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 152
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 151
Dual sugar gut-permeability testing on blood drop in animal models. 149
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 148
Molecular dissection of the tissue transglutaminase auto-antibody response in celiac disease 145
Development of a novel rapid non-invasive screening test for coeliac disease. 142
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 141
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 141
An Air-well sparging minifermenter system for high-throughput protein production 141
Interactome-Seq: A Protocol for Domainome Library Construction, Validation and Selection by Phage Display and Next Generation Sequencing 141
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 140
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 140
N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channels 139
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 138
Gluten ataxia: passive transfer in a mouse model. 131
Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells 131
Differential induction of IL-17, IL-10, and IL-9 in human T helper cells by B7h and B7.1 130
Profiling the Autoantibody Repertoire by Screening Phage-Displayed Human cDNA Libraries 130
Antibodies in proteomics I: generating antibodies 129
Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of i to channel complex 129
A definitive set of oligonucleotide primers for amplifying human V regions 128
Plasmid incompatibility: More compatible than previously thought? 128
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 126
Prevalence of celiac disease among risk groups and the general population in USA 126
A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies 126
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 125
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 125
A label-free immunoassay for Flavivirus detection by the Reflective Phantom Interface technology 125
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 124
Anti-idiotypic response in mice expressing human autoantibodies. 123
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca2+ homeostasis 123
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. 122
A Human Monoclonal Antibody Against Domain I Of beta 2-Glycoprotein I prevents Clotting and Fetal Loss Induced By Polyclonal Anti-Phospholipid Antibodies In Animal Models. 121
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 119
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 119
null 119
Engineering mammalian cell factories with SINEUP noncoding RNAs to improve translation of secreted proteins 118
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 117
Filtering "genic" open reading frames from genomic DNA samples for advanced annotation 117
Recombinant renewable polyclonal antibodies 115
null 114
null 114
A deep-blue OLED-based biochip for protein microarray fluorescence detection 114
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 114
A novel quantitative ELISA as accurate and reproducible tool to detect epidermal transglutaminase antibodies in patients with Dermatitis Herpetiformis 114
Rapid and simple dot immunobinding assay to detect anti human transglutaminase antibodies in coeliac disease 113
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 113
Human tissue transglutaminase ELISA: powerful massscreening diagnostic assay for coeliac disease 112
Triggering of B7h by the ICOS modulates maturation and migration of monocyte-derived dendritic cells 111
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies 110
Profiling celiac disease antibody repertoire 110
Transglutaminase 2-specific coeliac disease autoantibodies induce morphological changes and signs of inflammation in the small-bowel mucosa of mice 110
Binders based on dimerised immunoglobulin VH domains 109
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects 109
Mucosal tissue transglutaminase expression in celiac disease 108
Antibodies to transglutaminasefrom phage display libraries 107
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 106
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. 105
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 104
The transmembrane β-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current i to 103
null 100
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal-mucosa anti-transglutaminase antibodies 99
null 97
Protective role of anti-idiotypic network in celiac disease prone subjects 97
Characterizing monoclonal antibody epitopes by filtered gene fragment phagedisplay. 96
Antibodies against breain structures in a celiac patient with ataxic syndrome are produced in the intestine 96
Simple scale-up of recombinant antibody production using an UCOE containing vector 96
DEVELOPMENT OF CHLORAMBUCIL/HYDROXYCHLOROQUINE-LOADED ANTI-CD20 NANOPARTICLES FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA : IN VITRO MODEL 96
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 96
A zonulin-occludens toxin synthetic esapeptide modifies the intestinal permeabilità in in-vivo animal model 95
Site of syntesis of antibodies to A-gliadin and tissue-transglutaminase in celiac disease patients 95
Charecterization of tissue transglutaminase auto-antigenic response using cloned structural domains 95
Totale 14.018
Categoria #
all - tutte 41.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.368 0 0 0 0 0 0 0 0 0 228 791 349
2019/20204.032 217 199 226 702 277 571 413 450 351 228 267 131
2020/20212.622 257 178 260 310 204 276 147 219 144 276 105 246
2021/20221.709 87 114 68 139 65 157 74 55 207 179 140 424
2022/20232.673 257 331 215 382 267 485 26 241 290 25 116 38
2023/20241.217 81 78 73 94 155 195 225 271 22 23 0 0
Totale 18.332